TRIOCHEM PRODUCTS LTD.

Triochem Products Ltd has filed its quarterly disclosure regarding defaults on loan payments and principal repayments for the quarter ended June 30, 2026. The company reported no outstanding amounts or defaults on loans from banks, financial institutions, or unlisted debt securities. Total financial indebtedness, including short-term and long-term debt, was also reported as Nil. This filing is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Triochem Products Ltd has announced the closure of its trading window for the quarter ended June 30, 2026. This restriction applies to all Key Managerial Personnel (KMP), designated persons, directors, promoters, persons acting in concert, employees, and their immediate relatives, as well as individuals with contractual or fiduciary relationships with the company, including auditors, law firms, and consultants. The trading window will remain closed from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the aforementioned quarter. The company will announce the date of the Board Meeting to consider these results in due course. This measure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's internal code of conduct.

Triochem Products Ltd. announces that disclosures of Related Party Transactions on a consolidated basis under Regulation 23(9) of SEBI (LODR) (Amendment) Regulations, 2018 are not applicable to the company. This exemption is claimed under Regulation 15(2) of SEBI regulations, as the company's paid-up equity share capital is ₹24.5 Lakhs (less than ₹10 Crores) and net worth is ₹13.67 Crores (less than ₹25 Crores) as per the audited balance sheet as of March 31, 2025. The company confirms compliance if the regulation becomes applicable later.

Triochem Products Ltd confirms that it has not raised funds through Public Issue, Rights Issue, Preferential Issue, or Qualified Institutions Placement (QIP) for the quarter ended March 31, 2026. Consequently, the requirements regarding deviation or variation in the utilization of funds raised, as per Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are not applicable to the company.

Triochem Products Ltd held a board meeting on May 29, 2026, and approved the annual financial statements for the year ended March 31, 2026. The board also approved the audited financial results for the quarter and year ended March 31, 2026. The company recognized a gain of ₹1,116.65 lakhs as an exceptional item from the sale of assets. The company's operations were impacted by the Covid-19 pandemic, but the management believes there are no material adjustments required in the financial statements.

Triochem Products Ltd has scheduled a Board of Directors meeting on May 29, 2026, in Mumbai to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also review the audit report for the same period and the notice for the 54th Annual General Meeting for the year 2025-26. The trading window, which has been closed since April 1, 2025, will remain closed until 48 hours after the declaration of the audited financial results.

Triochem Products Ltd has filed its quarterly disclosure regarding defaults on payment of interest and repayment of principal amounts for the quarter ended March 31, 2026. The company reported no outstanding loans or revolving facilities from banks/financial institutions, and consequently, no defaults on these. Similarly, there were no outstanding unlisted debt securities (NCDs and NCRPS), leading to no defaults in this category. The total financial indebtedness of the company, including short-term and long-term debt, was also reported as Nil. This indicates a strong debt-free position for the company as of the reporting date.

Triochem Products Ltd, in accordance with Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and terms of the provision of Section 173 and Schedule IV of the Companies Act, 2013, held a separate meeting of the Independent Directors on Friday, 20th March 2026. The agenda included the review of the performance of Non-Independent Directors and the Board as a whole, the review of the performance of the chairperson of the company, and the assessment of the quality, quantity, and timeliness of the flow of information between the company management and the Board. The meeting commenced at 3.00 pm and ended at 4.10 pm.

Triochem Products Ltd has announced the closure of its trading window for the quarter ended 31st March 2026. The closure is in accordance with the 'Code of Conduct for Prevention of Insider Trading' of the company, SEBI (Prohibition of Insider Trading) Regulation, 2015, and the Bombay Stock Exchange (BSE) Circular No. LIST/COMP/01/2019-20. The trading window will remain closed from 1st April 2026 till 48 hours after the declaration of audited financial results of the company for the quarter and year ended 31st March 2026. This decision applies to all KMP, designated persons, Directors, promoters, persons acting in concert, employees of the company, along with their respective immediate relatives, and persons having contractual and fiduciary relations with the company. Insiders are advised not to deal in the shares of Triochem Products Limited during the closure of the trading window.

Triochem Products Ltd has announced a Board of Directors meeting scheduled for 20/03/2026. The agenda includes reviewing the performance of Non-Independent Directors, the Board of Directors, and the Chairperson. The meeting will also assess the quality, quantity, and timeliness of information flow between the company management and the Board. Any other business with the chair's permission will also be discussed.